PNC Financial Services Group Inc. Purchases 2,008 Shares of Phreesia, Inc. (NYSE:PHR)

PNC Financial Services Group Inc. grew its position in shares of Phreesia, Inc. (NYSE:PHR) by 9.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,445 shares of the company’s stock after purchasing an additional 2,008 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Phreesia were worth $565,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company raised its holdings in Phreesia by 3.3% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company’s stock worth $637,000 after purchasing an additional 905 shares during the last quarter. MetLife Investment Management LLC increased its stake in shares of Phreesia by 3.8% in the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company’s stock valued at $701,000 after acquiring an additional 1,120 shares in the last quarter. R Squared Ltd bought a new stake in shares of Phreesia in the 4th quarter valued at $30,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Phreesia by 9.9% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,015 shares of the company’s stock valued at $319,000 after acquiring an additional 1,258 shares in the last quarter. Finally, BankPlus Trust Department bought a new stake in shares of Phreesia in the 4th quarter valued at $34,000. Institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Robert W. Baird lowered their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price objective for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. KeyCorp lifted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, January 8th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Thursday, March 13th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $31.33.

Insiders Place Their Bets

In other news, COO Evan Roberts sold 3,519 shares of Phreesia stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14. Following the sale, the chief operating officer now directly owns 741,197 shares in the company, valued at $22,280,381.82. The trade was a 0.47 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Amy Beth Vanduyn sold 1,311 shares of Phreesia stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $34,885.71. Following the sale, the senior vice president now owns 115,633 shares in the company, valued at $3,076,994.13. The trade was a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 158,907 shares of company stock valued at $4,521,730 in the last three months. 5.80% of the stock is currently owned by insiders.

Phreesia Price Performance

PHR opened at $27.24 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 1.03. The firm’s fifty day moving average price is $27.32 and its two-hundred day moving average price is $24.00. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.